Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Penumbra ( (PEN) ) just unveiled an announcement.
Penumbra, Inc. announced that Don Kassing will retire from the Board of Directors on April 1, 2025, after 17 years of service. Kassing’s retirement, which follows his tenure as Presiding Director since 2015, did not stem from any disagreement with the company. His departure marks a significant transition for Penumbra, which has benefitted from his guidance through various phases of growth.
More about Penumbra
Penumbra, Inc. is the world’s leading thrombectomy company, focusing on innovative technologies for medical conditions like ischemic stroke and venous thromboembolism. The company’s portfolio, including computer assisted vacuum thrombectomy (CAVT), aims to improve patient outcomes globally by safely and efficiently removing blood clots.
YTD Price Performance: 26.31%
Average Trading Volume: 429,348
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $11.67B
See more data about PEN stock on TipRanks’ Stock Analysis page.
